These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26902421)

  • 1. Akt phosphorylates myc-associated zinc finger protein (MAZ), releases P-MAZ from the p53 promoter, and activates p53 transcription.
    Lee WP; Lan KH; Li CP; Chao Y; Lin HC; Lee SD
    Cancer Lett; 2016 May; 375(1):9-19. PubMed ID: 26902421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The DNA-binding and transcriptional activities of MAZ, a myc-associated zinc finger protein, are regulated by casein kinase II.
    Tsutsui H; Geltinger C; Murata T; Itakura K; Wada T; Handa H; Yokoyama KK
    Biochem Biophys Res Commun; 1999 Aug; 262(1):198-205. PubMed ID: 10448092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative proteomic identification of MAZ as a transcriptional regulator of muscle-specific genes in skeletal and cardiac myocytes.
    Himeda CL; Ranish JA; Hauschka SD
    Mol Cell Biol; 2008 Oct; 28(20):6521-35. PubMed ID: 18710939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical roles of DMP1 in human epidermal growth factor receptor 2/neu-Arf-p53 signaling and breast cancer development.
    Taneja P; Maglic D; Kai F; Sugiyama T; Kendig RD; Frazier DP; Willingham MC; Inoue K
    Cancer Res; 2010 Nov; 70(22):9084-94. PubMed ID: 21062982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional up-regulation of Sox9 by NF-κB in endometrial carcinoma cells, modulating cell proliferation through alteration in the p14(ARF)/p53/p21(WAF1) pathway.
    Saegusa M; Hashimura M; Suzuki E; Yoshida T; Kuwata T
    Am J Pathol; 2012 Aug; 181(2):684-92. PubMed ID: 22698986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sam68 functions as a transcriptional coactivator of the p53 tumor suppressor.
    Li N; Richard S
    Nucleic Acids Res; 2016 Oct; 44(18):8726-8741. PubMed ID: 27365047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of Myc-associated zinc finger protein with DCC, the product of a tumor-suppressor gene, during the neural differentiation of P19 EC cells.
    Ugai H; Li HO; Komatsu M; Tsutsui H; Song J; Shiga T; Fearon E; Murata T; Yokoyama KK
    Biochem Biophys Res Commun; 2001 Sep; 286(5):1087-97. PubMed ID: 11527412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
    Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
    Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EVI1 targets ΔNp63 and upregulates the cyclin dependent kinase inhibitor p21 independent of p53 to delay cell cycle progression and cell proliferation in colon cancer cells.
    Nayak KB; Kuila N; Das Mohapatra A; Panda AK; Chakraborty S
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1568-76. PubMed ID: 23665236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective transcription of p53 target genes by zinc finger-p53 DNA binding domain chimeras.
    Falke D; Fisher MH; Juliano RL
    Biochim Biophys Acta; 2004 Nov; 1681(1):15-27. PubMed ID: 15566940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional repression from the c-myc P2 promoter by the zinc finger protein ZF87/MAZ.
    Izzo MW; Strachan GD; Stubbs MC; Hall DJ
    J Biol Chem; 1999 Jul; 274(27):19498-506. PubMed ID: 10383467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation.
    Wang J; Ouyang W; Li J; Wei L; Ma Q; Zhang Z; Tong Q; He J; Huang C
    Cancer Res; 2005 Aug; 65(15):6601-11. PubMed ID: 16061640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
    Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
    Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
    Wunderlich M; Berberich SJ
    Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human oncoprotein MDM2 activates the Akt signaling pathway through an interaction with the repressor element-1 silencing transcription factor conferring a survival advantage to cancer cells.
    Singh S; Ramamoorthy M; Vaughan C; Yeudall WA; Deb S; Palit Deb S
    Cell Death Differ; 2013 Apr; 20(4):558-66. PubMed ID: 23238568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation by zinc-finger proteins Sp1 and MAZ involves interactions with the same cis-elements.
    Song J; Ugai H; Nakata-Tsutsui H; Kishikawa S; Suzuki E; Murata T; Yokoyama KK
    Int J Mol Med; 2003 May; 11(5):547-53. PubMed ID: 12684688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3.
    Lin J; Tang H; Jin X; Jia G; Hsieh JT
    Oncogene; 2002 May; 21(19):3082-8. PubMed ID: 12082540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factors that interact with p53 and Mdm2.
    Inoue K; Fry EA; Frazier DP
    Int J Cancer; 2016 Apr; 138(7):1577-85. PubMed ID: 26132471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress.
    Grönroos E; Terentiev AA; Punga T; Ericsson J
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12165-70. PubMed ID: 15295102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual function of MAZ mediated by FOXF2 in basal-like breast cancer: Promotion of proliferation and suppression of progression.
    Yu ZH; Lun SM; He R; Tian HP; Huang HJ; Wang QS; Li XQ; Feng YM
    Cancer Lett; 2017 Aug; 402():142-152. PubMed ID: 28577976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.